PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#regulatory

Tag

UK Autumn Statement to review life sciences regulation

UK Autumn Statement to review life sciences regulation

Among the measures unveiled in the UK government’s Autumn Statement, published on 17 November 2022, Chancellor of the Exchequer Jeremy Hunt said that there will be regulatory reform to encourage economic growth in key industries, including the life sciences.

22 Nov 2022
Read More
Trends Affecting Pharmacovigilance

Trends Affecting Pharmacovigilance

Pharmacovigilance (PV) – the proactive maintenance of drug safety through collection, detection, assessment, monitoring and prevention of adverse effects – has been evolving since the first concerns were raised over the negative effects of chloroform anaesthetic in the 1800s. Today, it is just as important that pharma, start-ups and regulators keep up to date with the latest trends to ensure that drugs are safe and monitoring practices remain fit for purpose.

21 Nov 2022
Read More
MHRA and NICE get Wellcome funding for regulation of mental health products

MHRA and NICE get Wellcome funding for regulation of mental health products

Wellcome has awarded £1.8m to the Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) so that they can investigate and produce guidance on regulation of digital mental health tools.  

7 Nov 2022
Read More
NICE develops proportionate approach to technology appraisals

NICE develops proportionate approach to technology appraisals

The National Institute for Health and Care Excellence (NICE) plans to speed up its processes for evaluating lower-risk treatments using a lighter touch approach. This will free up time to consider the increasing number of more complex applications. NICE states that this method will make its assessments faster, enabling quicker access to promising new treatments.

1 Nov 2022
Read More
EMA and HMA open big data regulatory documents to public consultation 

EMA and HMA open big data regulatory documents to public consultation 

The European Medicines Agency and the Heads of Medicines Agencies in the EU Member States are advancing their agenda to improve data quality for medicine regulation decision-making, publishing the draft Data Quality Framework and a draft good practice guide for the use of the EU metadata catalogue of real-world data sources for consultation this month. Read more.

1 Nov 2022
Read More
Virtual Breakfast Briefing: Shaping the UK’s position in the international community- innovation and regulatory perspectives

Virtual Breakfast Briefing: Shaping the UK’s position in the international community- innovation and regulatory perspectives

PharmaMedic is delighted to announce our next virtual event on Thursday 28th October 2021 at 8 am. As the UK life sciences sector continues its journey outside the EU, it’s time to forge a new role in the international community. This briefing will highlight some of the critical considerations we face from both innovation and regulatory perspectives. Learn more about the agenda and register here.

6 Oct 2021
Read More

Categories

  • Awards
  • Consultants
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #ClinicalTrials #DCVMN #diagnostics #drugdevelopment #drugpricing #EC #EMA #EU #FDA #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #mentalhealth #mhra #NICE #outsourcing #PatientAccess #pharmaregulation #pharmatrends #projectorbis #quality #rarediseases #regulation #regulatory #ukpharma AI Biotech Capabilities Brochure Clinical Research Clinical Resourcing COVID-19 CRO DITTurkey Drug Price Healthcare Medical Affairs medicaldevices Patient Care Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital